HUP0900616A2 - 2,3,4-Benzotiadiazepin-2,2-dioxid származékok - Google Patents

2,3,4-Benzotiadiazepin-2,2-dioxid származékok

Info

Publication number
HUP0900616A2
HUP0900616A2 HU0900616A HUP0900616A HUP0900616A2 HU P0900616 A2 HUP0900616 A2 HU P0900616A2 HU 0900616 A HU0900616 A HU 0900616A HU P0900616 A HUP0900616 A HU P0900616A HU P0900616 A2 HUP0900616 A2 HU P0900616A2
Authority
HU
Hungary
Prior art keywords
benzodiazepine
dioxide derivatives
dioxide
derivatives
Prior art date
Application number
HU0900616A
Other languages
English (en)
Inventor
Jozsef Dr Fetter
Ferenc Dr Bertha
Balazs Molnar
Gyula Dr Simig
Jozsef Dr Barkoczy
Balazs Dr Volk
Gyorgy Dr Luvay
Istvan Dr Gacsalyi
Gabor Gigler
Hajnalka Kompagne
Bernadett Marko
Katalin Nagy
Puter Dr Kiricsi
Laszlo Dr Harsing
Gabor Dr Szunasi
Original Assignee
Egis Gyogyszergyar Nyilvanosan Mikodi Ruszvunytarsasag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Nyilvanosan Mikodi Ruszvunytarsasag filed Critical Egis Gyogyszergyar Nyilvanosan Mikodi Ruszvunytarsasag
Priority to HU0900616A priority Critical patent/HUP0900616A2/hu
Publication of HU0900616D0 publication Critical patent/HU0900616D0/hu
Priority to PCT/HU2010/000103 priority patent/WO2011039554A2/en
Priority to EP10818064.7A priority patent/EP2483257B1/en
Priority to EA201290179A priority patent/EA201290179A1/ru
Priority to JP2012531504A priority patent/JP2013505980A/ja
Publication of HUP0900616A2 publication Critical patent/HUP0900616A2/hu
Priority to US13/418,869 priority patent/US20120252784A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/36—Seven-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/24—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/78—Halides of sulfonic acids
    • C07C309/79—Halides of sulfonic acids having halosulfonyl groups bound to acyclic carbon atoms
    • C07C309/81—Halides of sulfonic acids having halosulfonyl groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU0900616A 2009-09-29 2009-09-29 2,3,4-Benzotiadiazepin-2,2-dioxid származékok HUP0900616A2 (hu)

Priority Applications (6)

Application Number Priority Date Filing Date Title
HU0900616A HUP0900616A2 (hu) 2009-09-29 2009-09-29 2,3,4-Benzotiadiazepin-2,2-dioxid származékok
PCT/HU2010/000103 WO2011039554A2 (en) 2009-09-29 2010-09-29 2,3,4-benzothiadiazepine-2,2-dioxide derivatives
EP10818064.7A EP2483257B1 (en) 2009-09-29 2010-09-29 2,3,4-benzothiadiazepine-2,2-dioxide derivatives
EA201290179A EA201290179A1 (ru) 2009-09-29 2010-09-29 Производные 2,3,4-бензотиадиазепин-2,2-диоксида
JP2012531504A JP2013505980A (ja) 2009-09-29 2010-09-29 ２，３，４−ベンゾチアジアゼピン−２，２−ジオキシド誘導体
US13/418,869 US20120252784A1 (en) 2009-09-29 2012-03-13 2,3,4-benzothiadiazepine-2,2-dioxide derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0900616A HUP0900616A2 (hu) 2009-09-29 2009-09-29 2,3,4-Benzotiadiazepin-2,2-dioxid származékok

Publications (2)

Publication Number Publication Date
HU0900616D0 HU0900616D0 (en) 2009-11-30
HUP0900616A2 true HUP0900616A2 (hu) 2011-04-28

Family

ID=89989279

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0900616A HUP0900616A2 (hu) 2009-09-29 2009-09-29 2,3,4-Benzotiadiazepin-2,2-dioxid származékok

Country Status (6)

Country Link
US (1) US20120252784A1 (hu)
EP (1) EP2483257B1 (hu)
JP (1) JP2013505980A (hu)
EA (1) EA201290179A1 (hu)
HU (1) HUP0900616A2 (hu)
WO (1) WO2011039554A2 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108530293B (zh) * 2018-05-23 2021-02-19 王华平 一种高纯度氯代2-羧基二苯甲酮的制备方法

Also Published As

Publication number Publication date
WO2011039554A2 (en) 2011-04-07
EA201290179A1 (ru) 2012-12-28
EP2483257A2 (en) 2012-08-08
WO2011039554A3 (en) 2011-06-16
JP2013505980A (ja) 2013-02-21
HU0900616D0 (en) 2009-11-30
EP2483257B1 (en) 2014-03-05
US20120252784A1 (en) 2012-10-04

Similar Documents

Publication Publication Date Title
IL206765A0 (en) 4,5-dihydro-oxazol-2-yl-amine derivatives
HK1179617A1 (en) 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro- [1,4]oxazepin-5-ylamine compounds 2567--[14]-3- 2367--[14]-5-
IL201973A0 (en) 3,3-spiroindolinone derivatives
AP2012006216A0 (en) Benzimidazole-imidazole derivatives.
HK1149756A1 (en) Isoxazolo-pyridine derivatives
IL205753A0 (en) Isoxazolo-pyridazine derivatives
EP2120569A4 (en) SPIROCHROMANONDERIVATE
IL202020A0 (en) Spiroindolinone derivatives
IL202830A0 (en) Indazolamide derivatives
IL205755A0 (en) Isoxazolo-pyrazine derivatives
ZA201001797B (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
IL200618A0 (en) Aza-pyridopyrimidinone derivatives
SI2356123T1 (sl) Piro-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo(e)azuleni
SI2513119T1 (sl) 3,4,4a,10b-tetrahidro-1H-tiopirano-(4,3-c)izokinolinski derivati
IL202667A0 (en) Isoxazole-imidazole derivatives
EP2459573A4 (en) SUBSTITUTED 1,2-AZABORIN HETEROCYCLES
PL2245028T3 (pl) Pochodne 5-aminocyklilometyloksazolidyn-2-onu
GB0820231D0 (en) Airbagmodul, airbagmodulanordung und befestigungsverfahren
EP2133347A4 (en) 1-BIARYLAZETIDINONDERIVATE
EP2448934A4 (en) DERIVATIVES OF 2-CARBOXAMIDE-7-PIPERAZINYL-BENZOFURAN
HK1141009A1 (en) Sulfonyl-quinoline derivatives
IL202159A0 (en) Piperidine-amide derivatives
IL201444A0 (en) New 4, 8 - diphenyl - polyazanaphthalene derivatives
HK1162032A1 (en) 1,1,1-trifluoro-2-hydroxypropyl compounds 111--2-
HK1146276A1 (en) Thiadiazinone derivatives

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished